Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GINS3 mRNA | CTD | PMID:36331819 | 17beta-estradiol | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GINS3 mRNA | CTD | PMID:19167446 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GINS3 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of GINS3 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GINS3 mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of GINS3 mRNA | CTD | PMID:21179406 | 2-palmitoylglycerol | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of GINS3 mRNA | CTD | PMID:37199045 | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of GINS3 mRNA | CTD | PMID:20713471 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of GINS3 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of GINS3 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of GINS3 mRNA | CTD | PMID:25825206 | acetamide | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of GINS3 mRNA | CTD | PMID:31881176 | afimoxifene | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | afimoxifene inhibits the reaction [Estrogens results in increased expression of GINS3 mRNA] | CTD | PMID:21233418 | all-trans-retinoic acid | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GINS3 mRNA | CTD | PMID:21934132 and PMID:33167477 | arsane | decreases methylation | ISO | GINS3 (Homo sapiens) | 6480464 | Arsenic results in decreased methylation of GINS3 3' UTR | CTD | PMID:31135185 | arsenic atom | decreases methylation | ISO | GINS3 (Homo sapiens) | 6480464 | Arsenic results in decreased methylation of GINS3 3' UTR | CTD | PMID:31135185 | arsenite(3-) | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to GINS3 mRNA] | CTD | PMID:32406909 | azathioprine | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of GINS3 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GINS3 mRNA | CTD | PMID:32234424 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | benzo[a]pyrene diol epoxide I | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GINS3 mRNA | CTD | PMID:25181051 | calcitriol | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of GINS3 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of GINS3 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GINS3 mRNA | CTD | PMID:25979313 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of GINS3 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GINS3 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of GINS3 mRNA | CTD | PMID:27392435 | cocaine | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Cocaine results in decreased expression of GINS3 mRNA | CTD | PMID:27899881 | copper atom | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of GINS3 mRNA | CTD | PMID:26033743 | copper atom | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of GINS3 mRNA | CTD | PMID:20971185 | copper(0) | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of GINS3 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of GINS3 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of GINS3 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of GINS3 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GINS3 mRNA | CTD | PMID:20106945 | cyclosporin A | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | Cyclosporine affects the expression of GINS3 mRNA | CTD | PMID:25562108 | deguelin | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | deguelin results in decreased expression of GINS3 mRNA | CTD | PMID:33512557 | dibutyl phthalate | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of GINS3 mRNA | CTD | PMID:21266533 | dioxygen | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GINS3 mRNA | CTD | PMID:24236059 and PMID:26516004 | dorsomorphin | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GINS3 mRNA | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of GINS3 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA | CTD | PMID:19167446 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of GINS3 mRNA | CTD | PMID:25629700 | furan | increases methylation | ISO | Gins3 (Rattus norvegicus) | 6480464 | furan results in increased methylation of GINS3 gene | CTD | PMID:22079235 | gentamycin | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of GINS3 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of GINS3 mRNA | CTD | PMID:20044591 | leflunomide | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of GINS3 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GINS3 mRNA | CTD | PMID:23649840 | niclosamide | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of GINS3 mRNA | CTD | PMID:36318118 | oxaliplatin | decreases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of GINS3 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | ISO | Gins3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GINS3 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GINS3 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GINS3 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GINS3 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of GINS3 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GINS3 mRNA | CTD | PMID:29067470 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GINS3 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of GINS3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GINS3 mRNA | CTD | PMID:27188386 | picoxystrobin | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of GINS3 mRNA | CTD | PMID:33512557 | piroxicam | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of GINS3 mRNA | CTD | PMID:21858171 | rac-lactic acid | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GINS3 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of GINS3 mRNA | CTD | PMID:19167446 | rotenone | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of GINS3 mRNA | CTD | PMID:33512557 | SB 431542 | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GINS3 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GINS3 mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium dichromate | affects expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | sodium bichromate affects the expression of GINS3 mRNA | CTD | PMID:22110744 | testosterone | multiple interactions | ISO | GINS3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of GINS3 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Testosterone results in increased expression of GINS3 mRNA | CTD | PMID:21475673 | testosterone | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of GINS3 mRNA | CTD | PMID:21592394 | thioacetamide | increases expression | ISO | Gins3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of GINS3 mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | ISO | Gins3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GINS3 mRNA | CTD | PMID:25729387 | trichostatin A | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | trichostatin A affects the expression of GINS3 mRNA | CTD | PMID:28542535 | valproic acid | decreases methylation | ISO | GINS3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of GINS3 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | GINS3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GINS3 mRNA | CTD | PMID:25979313 | zearalenone | decreases expression | ISO | GINS3 (Homo sapiens) | 6480464 | Zearalenone results in decreased expression of GINS3 mRNA | CTD | PMID:19371625 | |